Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 4 Pain, Postoperative 2 Neoplasms 2 Agnosia 2 Recurrence 1 Postoperative Cognitive Complications 1 Obturator Nerve Block 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplastic Cells, Circulating 1 Myofibroma 1 Melanoma 1 Liver Neoplasms 1 Leiomyoma 1 Inflammatory Bowel Diseases 1 Diverticulitis 1 Delirium 1 Colonic Neoplasms 1 Cancer Surgery 1

Interventions

Sorafenib 68 Bevacizumab 44 Oxaliplatin 25 Doxorubicin 22 Gemcitabine 21 Fluorouracil 21 Radiosurgery 20 Nivolumab 19 durvalumab 18 Radiofrequency Ablation 18 pembrolizumab 17 lenvatinib 17 Cisplatin 17 Capecitabine 17 atezolizumab 14 Leucovorin 14 Hepatectomy 14 Radiotherapy 12 tremelimumab 10 Irinotecan 10 Drug Therapy 10 Cyclophosphamide 10 Carboplatin 10 Blood Specimen Collection 10 Ipilimumab 9 regorafenib 8 Liver Transplantation 8 Everolimus 8 Cryosurgery 8 Chemotherapy, Adjuvant 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Liver Neoplasms × Anesthesia, Spinal × Clear all

NCT03715517 2026-02-05

SAFER-L

University of Manitoba

Phase NA Recruiting

Gastrointestinal

Agnosia, Liver Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡